Literature DB >> 16932531

Mechanisms of disease: neuropathic pain--a clinical perspective.

Ralf Baron1.   

Abstract

Neuropathic pain syndromes-pain after a lesion or disease of the peripheral or central nervous system-are clinically characterized by spontaneous and evoked types of pain, which are underpinned by various distinct pathophysiological mechanisms in the peripheral and central nervous systems. In some patients, the nerve lesion triggers molecular changes in nociceptive neurons, which become abnormally sensitive and develop pathological spontaneous activity. Inflammatory reactions of the damaged nerve trunk can induce ectopic nociceptor activity, causing spontaneous pain. The hyperactivity in nociceptors induces secondary changes in processing neurons in the spinal cord and brain, so that input from mechanoreceptive A-fibers is perceived as pain. Neuroplastic changes in the central pain modulatory systems can lead to further hyperexcitability. The treatment of neuropathic pain is still unsatisfactory, and a new hypothetical concept has been proposed, in which pain is analyzed on the basis of underlying mechanisms. The increased knowledge of pain-generating mechanisms and their translation into symptoms and signs might eventually allow a dissection of the mechanisms that operate in each patient. If a precise clinical phenotypic characterization of the neuropathic pain is combined with a selection of drugs that act on those mechanisms, it should ultimately be possible to design optimal treatments for individuals. This review discusses the conceptual framework of the novel mechanism-based classification, encouraging the reader to see neuropathic pain as a clinical entity rather than a compilation of single disease states.

Entities:  

Mesh:

Year:  2006        PMID: 16932531     DOI: 10.1038/ncpneuro0113

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  205 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Spinal cord stimulation: neurophysiological and neurochemical mechanisms of action.

Authors:  Yun Guan
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 3.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  Mas-related G-protein-coupled receptors inhibit pathological pain in mice.

Authors:  Yun Guan; Qin Liu; Zongxiang Tang; Srinivasa N Raja; David J Anderson; Xinzhong Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-19       Impact factor: 11.205

Review 5.  [Maladaptive plasticity in chronic and neuropathic pain].

Authors:  M Lotze
Journal:  Schmerz       Date:  2016-04       Impact factor: 1.107

Review 6.  Dynorphin A analogs for the treatment of chronic neuropathic pain.

Authors:  Sara M Hall; Yeon Sun Lee; Victor J Hruby
Journal:  Future Med Chem       Date:  2016-01-29       Impact factor: 3.808

7.  Analgesic effects of ketamine infusion therapy in korean patients with neuropathic pain: A 2-week, open-label, uncontrolled study.

Authors:  Jin Gu Kang; Chul Joong Lee; Tae Hyeong Kim; Woo Seok Sim; Byung Seop Shin; Sang Hyun Lee; Francis Sahngun Nahm; Pyung Bok Lee; Yong Chul Kim; Sang Chul Lee
Journal:  Curr Ther Res Clin Exp       Date:  2010-04

8.  Calcitonin gene-related peptide contributes to peripheral nerve injury-induced mechanical hypersensitivity through CCL5 and p38 pathways.

Authors:  Jennifer T Malon; Ling Cao
Journal:  J Neuroimmunol       Date:  2016-05-06       Impact factor: 3.478

9.  Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain.

Authors:  Ji Zhang; Xiang Qun Shi; Stefania Echeverry; Jeffrey S Mogil; Yves De Koninck; Serge Rivest
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 10.  TRP channels: potential drug target for neuropathic pain.

Authors:  Lovish Marwaha; Yashika Bansal; Raghunath Singh; Priyanka Saroj; Ranjana Bhandari; Anurag Kuhad
Journal:  Inflammopharmacology       Date:  2016-10-18       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.